oleoylglycine
Modify Date: 2025-08-25 18:33:45
oleoylglycine structure
|
Common Name | oleoylglycine | ||
|---|---|---|---|---|
| CAS Number | 2601-90-3 | Molecular Weight | 339.513 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 525.6±43.0 °C at 760 mmHg | |
| Molecular Formula | C20H37NO3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 271.7±28.2 °C | |
Use of oleoylglycineN-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. |
| Name | N-Oleoylglycine |
|---|---|
| Synonym | More Synonyms |
| Description | N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite CB1 Receptor Akt |
| In Vitro | N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. N-Oleoyl glycine (1, 5, 10, 20, 50 μM) dose- and time-dependently stimulates 3T3-L1 adipogenesis after treatment for 1-10 days via activation of CB1R. N-Oleoyl glycine also elevates Akt signaling pathway during the differentiation of 3T3-L1 adipocytes[1]. |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 525.6±43.0 °C at 760 mmHg |
| Molecular Formula | C20H37NO3 |
| Molecular Weight | 339.513 |
| Flash Point | 271.7±28.2 °C |
| Exact Mass | 339.277344 |
| PSA | 66.40000 |
| LogP | 6.57 |
| Vapour Pressure | 0.0±3.0 mmHg at 25°C |
| Index of Refraction | 1.478 |
| InChIKey | HPFXACZRFJDURI-KTKRTIGZSA-N |
| SMILES | CCCCCCCCC=CCCCCCCCC(=O)NCC(=O)O |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2924199090 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2924199090 |
|---|---|
| Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: HCMV UL50
External Id: HMS1262
|
|
Name: Inhibition of recombinant human GlyT2a expressed in Xenopus laevis oocytes assessed a...
Source: ChEMBL
Target: Sodium- and chloride-dependent glycine transporter 2
External Id: CHEMBL4481231
|
|
Name: Inhibition of recombinant human GlyT2a expressed in Xenopus laevis oocytes assessed a...
Source: ChEMBL
Target: Sodium- and chloride-dependent glycine transporter 2
External Id: CHEMBL4481230
|
|
Name: Cell-based high throughput primary assay to identify activators of GPR151
Source: The Scripps Research Institute Molecular Screening Center
Target: RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id: GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
Name: Antiinflammatory activity against IFN-gamma-stimulated human HaCaT cells assessed as ...
Source: ChEMBL
Target: HaCaT
External Id: CHEMBL1674456
|
|
Name: Stabilization of p53 in human papillomavirus-positive cells
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: Cellular tumor antigen p53
External Id: HMS1485
|
|
Name: Discovering small molecule activators of G protein-gated inwardly-rectifying potassiu...
Source: 15621
Target: G protein-activated inward rectifier potassium channel 2
External Id: VANDERBILT_HTS_GIRK2_MPD
|
|
Name: Cytotoxicity against human HaCaT cells at 50 to 100 uM after 24 hrs by MTT assay
Source: ChEMBL
Target: HaCaT
External Id: CHEMBL1674457
|
|
Name: Degradation half life in human plasma at 1000 ng/ml by LC-MS/MS analysis
Source: ChEMBL
Target: N/A
External Id: CHEMBL4481223
|
Total 22, Current Page 1 of 3
1
2
3
| N-(1-Oxo-9-octadecenyl)-(Z)-glycine |
| N-[(9Z)-9-Octadecenoyl]glycine |
| oleoylglycine |
| N-Oleoylglycine |
| N-[(9Z)-Octadec-9-enoyl]glycine |